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CONTINUOUS cell lines established from human tissue are useful for advancing many areas of biomedical research. Cross-contamination of cell lines, defined as contamination of cell lines with unrelated cells from another cell line, is a common, long-standing and recurring problem. 1, 2 Nelson-Rees et al reported one of the largest demonstrations of cross-contamination, finding widespread cross-contamination of many cell lines by HeLa. 3 Since then, there has been an increasing number of published reports of cell line cross-contamination. In 1984 Hukku et al reported that of 275 cultures sent to their laboratory for analysis in an 18-month period 35% of all cell lines and 36% of human cell lines were contaminated, including 25% by cells of another species and 11% by another human cell line. 4 In 1999 there were high levels of cross-contaminants in a cell line bank of the German Collection of Microorganisms and Cell Cultures, affecting 45 of 252 human cell lines (18%) supplied by 27 of 93 original donors (29%). 5 Cell line cross-contamination may alter the results of research that is based on cell culture experiments. Other consequences of cell line cross-contamination are the inability to compare research results between laboratories, decreased reproducibility of experiments, financial loss, and problems with drug licensing and patent filing.
Various methods of detecting cell line crosscontamination have been used, including enzyme polymorphisms, HLA typing, karyotyping, DNA polymorphisms and DNA fingerprinting. 2 The concept of DNA fingerprinting began after the discovery of hypervariable regions in DNA. 6 Its use for cell authentication was first described in 1988 by Masters 7 and Thacker 8 et al. The sensitivity of DNA fingerprinting for cell authentication was improved by PCR based microsatellite typing, as first used in 1994 by King et al. 9 The further development of STR profiling techniques for human individual identification paved the way for its use in cell authentication and standardization, and this technique was suggested to provide an international reference standard for human cell lines.
2,10 DNA fingerprinting is currently the method of choice for cell line authentication. 11 We previously established a panel of transitional cell cancer cell lines at University of Michigan. [12] [13] [14] Noting several inconsistencies between recent laboratory results and our prior reports led to the systematic authentication of our cell lines. We describe the DNA fingerprints of these cell lines and confirm that crosscontamination continues to be a serious and significant problem.
MATERIALS AND METHODS
Cell Culture
The transitional cell carcinoma cell lines UM-UC-1, UM-UC-2, UM-UC-3, UM-UC-6, UM-UC-9, UM-UC-10, UM-UC-11, UM-UC-13, UM-UC-14, UM-UC-16, T24 and KU7 were obtained from cryopreserved cells frozen during more than 25 years. UM-UC-3 from ATCC was also used. Cells were maintained in Eagle's minimum essential medium (Mediatech, Herndon, Virginia) supplemented with 2 mM L-glutamine, 10% fetal bovine serum, 100 U/ml penicillin and 100 g/ml streptomycin at 37C in a humidified chamber with 5% CO 2 . Cells were passed with 0.25% trypsin in Hanks medium (SigmaAldrich®) when confluent. All cultures were free of bacterial, fungal and Mycoplasma contamination.
DNA Extraction and Sequencing
Genomic DNA was isolated from 2 ϫ 10 6 cells using a QIAamp® DNA mini kit. DNA (1 ng) from each cell line was used for STR profiling. The DNA concentration was determined by light absorption at 260 nm. DNA samples from the cell lines were also sent for sequence analysis for the TP53 gene.
STR Amplification and Typing
STR loci and a segment of the X-Y homologous gene amelogenin were amplified using AmpFlSTR™ Profiler Plus™ (detecting D3S1358, vWA, FGA, TH01, TPOX, CSF1PO, D5S818, D13S317 and D7S820 loci, and amelogenin) and COfiler® (detecting D3S1358, D16S539, TH01, TPOX, CSF1PO and D7S820 loci) PCR amplification kits according to manufacturer instructions in a GeneAmp® PCR system 9700. Electrophoretic analysis was done using POP-4TM performance optimized polymer 4 with an ABI PRISM 310 Genetic Analyzer. The length of 
p53 IHC Staining
UM-UC-6 (WT for p53 on sequencing and p53 negative on IHC) and UM-UC-14 (mutation for p53 on sequencing and p53 positive on IHC) served as IHC controls. Primary antip53 antibodies (clone PAb 240 or PAb 1801) were used at a dilution of 1:200. The 240 antibody detects only mutant p53 protein, whereas the 1801 antibody detects WT and mutant p53 proteins. Cultured cells were grown on sterile glass slides overnight at 37C. The slides were washed with PBS and fixed for 5 minutes in Ϫ10C methanol. After washing in PBS the slides were incubated for 5 to 10 minutes in 0.1% to 1% hydrogen peroxide in PBS to quench endogenous peroxidase activity. The slides were blocked using 1% serum in PBS for 30 minutes before overnight incubation at 4C with each primary antibody diluted 1:200 in blocking solution. Primary antibodies were detected using their respective ABC Elite kits (Vector Laboratories, Burlingame, California). Color was developed with diaminobenzidine. The sections were then counterstained with hematoxylin, dehydrated and mounted. Using antibody 1801 p53 scoring was reported as no (Ϫ) or over (ϩϪϩϩϩ) expression, presumably representing a mutant form of the protein. Staining with antibody 240 was considered to indicate the presence of a mutant p53 protein. 
RESULTS
Each of the 12 urothelial carcinoma cell lines were analyzed by STR profiling at 2 to 5 different passages. Figures 1 to 10 show the DNA fingerprinting profiles. When we compared the cell line STR profiles, we found that the UM-UC-2 and T24 cell lines had essentially identical profiles ( figs. 1 to 3) , as independently verified elsewhere. T24 STR profiles matched those of early and intermediate passage UM-UC-2, demonstrating that UM-UC-2 was contaminated with T24 at an early stage. STR profiles of the other cell lines were distinct from each other (figs. 4 to 6). In each cell line there was at least 90% concordance in their respective profiles at different passages. Figures 1 to 3 and 8 to  10 show examples of STR profiles at different passages. Differences in the height of peaks at various loci were commonly seen at different passages.
Several cell lines had previously been transduced with the GFP marker gene. 15 Transduction of UM-UC-6, UM-UC-14 and KU7 with GFP did not alter the STR profiles. Figure 7 shows KU7 and KU7-GFP STR profiles. We found a marked discordance between the STR profiles of UM-UC-3 Figure 7 . STR profiles comparing KU7 bladder cancer cell line with KU7 transduced with GFP marker and UM-UC-3-GFP (figs. 8 to 10). To ascertain whether gene transduction altered the STR profile we examined the TP53 status of UM-UC-3, which has been described as having large deletions among exons 5/6 in TP53.
14 In contrast to our previous report, DNA sequencing analysis for the p53 gene in UM-UC-3 from our laboratory and from ATCC demonstrated that it is WT for exons 5 to 9 but it has a missense substitution in exon 4, a base substitution in exon 11, a noncoding deletion in exon 9, and a noncoding deletion and substitution in intron 9. These features are also different from those of UM-UC-3-GFP, which only had a frameshift deletion in position 39 of exon 5, demonstrating that UM-UC-3-GFP is contaminated ( fig. 11) . Furthermore, in contrast to our previous report, UM-UC-3 demonstrated strong staining for p53 on IHC analysis using the 1801 and 240 antibodies ( fig. 12 ). 14 We have also previously reported large deletions among exons 5/6 of TP53 in UM-UC-16.
14 Upon reanalysis of this cell line we found only a 7 bp frameshift deletion in exons 5 and 6, and a missense mutation in exon 4.
In this study we used 2 PCR amplification kits to determine the gene signature of the cell lines, including AmpFlSTR Profiler Plus, which detects 9 loci, and COfiler, which detects 6 loci. The 2 kits detect 5 similar loci. We found that detecting only 6 loci using the COfiler kit was sufficient to determine the identity of the cell lines.
DISCUSSION
It has been reported that 17% to 36% of cell cultures in use are cross-contaminated by intraspecies contamination (unrelated cells from the same species) or interspecies contamination (cells from another species).
1 Quality control for cell line crosscontamination is not regularly practiced at most laboratories despite the obvious importance and frequency of the problem. This may be due to several factors, including 1) failure to appreciate the occurrence of cross-contamination because it is often not visually recognizable, 2) unsuitability of detection methods for extensive cell culture screening and 3) lack of awareness of cross-contamination due to insufficient reporting. 1 Cell lines derived from bladder carcinoma have frequently been found to be cross-contaminated with T24 cells. 16 -19 The ECV304 cell line, which was widely considered a model cell line for endothelial cells, has also been reported to be a subclone of the T24 cell line. 20 In this study we describe another bladder cancer cell line, UM-UC-2, which is actually T24 due to cross-contamination at the source.
The STR profiling technique uses fluorescence based PCR and multiple dye technology to enable the detection of loci with overlapping size ranges. This technique was developed to identify individuals for forensic purposes. 10 Using this method various polymorphic STR loci are amplified by PCR using commercial primers. PCR products are then read against size standards by automated fluorescence detectors. The accuracy of this PCR technique is less than 1 bp. 2 STR profiling has been investigated for its use in detecting cell line cross-contamination. It was shown to provide an efficient, rapid and reliable means of authenticating cell lines. 2 In a study that used this technique to evaluate cell lines obtained worldwide STR profiling was also shown to provide a universal standard reference for human cell lines. 2 In our study 1 ng DNA was able to provide sufficient peak heights to evaluate the specific loci. Differences in peak heights within cell lines may be due to differential amplification efficiency of the loci, experimental variation or the number of allele copies present. In normal human DNA most STR loci have 2 alleles. However, STR loci in cancer cells may have additional copies of the allele due to genetic instability. Although it has been reported that long-term cultures and subcloning may result in alterations in DNA fingerprinting profiles that are divergent from their parental origin, 11 we have not verified this observation. UM-UC-3 cells were stable from different sources obtained during more than 25 years. Some investigators have found that viral transformation or long-term exposure to chemotherapeutic agents may produce sublines that have different STR profiles 2 but tend to remain similar to the parental cell line.
The finding that UM-UC-2 was contaminated led us to reassess our previously reported cell lines. We found that UM-UC-3-GFP was also contaminated and had a markedly different STR profile than UM-UC-3. This was confirmed by significant differences in TP53 mutation in the 2 cell lines. The other human bladder cancer cell lines had unique STR profiles that did not change with passage or GFP transduction. The table lists the STR profiles of our cell lines. We also found differences in TP53 in UM-UC-3 and UM-UC-16 cells, and on IHC for p53 in UM-UC-3 compared to findings in our prior report. 14 We observed that using 6 loci detection screening (D3S1358, D16S539, TH01, TPOX, CSF1PO and D7S820) was sufficient to authenticate our cell lines. While this approach is more cost-effective for screening cell lines, additional confirmation can be obtained by 10 loci screening. The reported profiles can be used to verify the identity of our cell lines.
CONCLUSIONS
STR profiling provides a unique genetic signature of human cell lines that does not change with passage or GFP transduction. Using STR profiling we noted that UM-UC-2 is actually T24, apparently due to cross-contamination shortly after establishing the cell line. STR profiling also demonstrated that UM-UC-3-GFP is not related to UM-UC-3. Investigators should be aware of the continuing problem of cell line cross-contamination. Our results demonstrate that DNA fingerprinting using a 6 loci STR profiling technique is an easy and reliable tool that can be used to identify cell lines.
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